1. Home
  2. RAIL vs CRVS Comparison

RAIL vs CRVS Comparison

Compare RAIL & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RAIL
  • CRVS
  • Stock Information
  • Founded
  • RAIL 1901
  • CRVS 2014
  • Country
  • RAIL United States
  • CRVS United States
  • Employees
  • RAIL N/A
  • CRVS N/A
  • Industry
  • RAIL Railroads
  • CRVS Biotechnology: Pharmaceutical Preparations
  • Sector
  • RAIL Industrials
  • CRVS Health Care
  • Exchange
  • RAIL Nasdaq
  • CRVS Nasdaq
  • Market Cap
  • RAIL 231.4M
  • CRVS 516.0M
  • IPO Year
  • RAIL N/A
  • CRVS 2016
  • Fundamental
  • Price
  • RAIL $8.89
  • CRVS $4.99
  • Analyst Decision
  • RAIL
  • CRVS Buy
  • Analyst Count
  • RAIL 0
  • CRVS 4
  • Target Price
  • RAIL N/A
  • CRVS $12.83
  • AVG Volume (30 Days)
  • RAIL 261.3K
  • CRVS 1.6M
  • Earning Date
  • RAIL 11-12-2024
  • CRVS 11-12-2024
  • Dividend Yield
  • RAIL N/A
  • CRVS N/A
  • EPS Growth
  • RAIL N/A
  • CRVS N/A
  • EPS
  • RAIL N/A
  • CRVS N/A
  • Revenue
  • RAIL $548,333,000.00
  • CRVS N/A
  • Revenue This Year
  • RAIL $63.43
  • CRVS N/A
  • Revenue Next Year
  • RAIL $5.04
  • CRVS N/A
  • P/E Ratio
  • RAIL N/A
  • CRVS N/A
  • Revenue Growth
  • RAIL 52.11
  • CRVS N/A
  • 52 Week Low
  • RAIL $2.40
  • CRVS $1.30
  • 52 Week High
  • RAIL $16.10
  • CRVS $10.00
  • Technical
  • Relative Strength Index (RSI)
  • RAIL 38.38
  • CRVS 28.00
  • Support Level
  • RAIL $8.74
  • CRVS $3.77
  • Resistance Level
  • RAIL $10.98
  • CRVS $7.44
  • Average True Range (ATR)
  • RAIL 0.67
  • CRVS 0.60
  • MACD
  • RAIL -0.02
  • CRVS -0.41
  • Stochastic Oscillator
  • RAIL 8.75
  • CRVS 25.85

About RAIL FreightCar America Inc.

FreightCar America Inc is a manufacturer of railcars and components, serving diverse transportation needs primarily in North America. The company designs and produces a wide range of railcar types, including box cars, hoppers, covered hoppers, gondolas, and flat cars for both intermodal and non-intermodal freight. Its clientele includes shippers, railroads, and financial institutions. The company has two segments: Manufacturing and Parts. The Manufacturing segment encompasses new railcar manufacturing, used railcar sales, leasing, and major rebuilds, while the Parts segment, along with corporate activities, constitutes Corporate and Other. The company's revenue is predominantly derived from its Manufacturing segment, with all revenue generated within the United States.

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical engaged in developing drugs and antibodies that target the critical cellular elements of the immune system. It focuses on the development of immune modulator product candidates to treat COVID-19, T-cell lymphomas, other cancers, and autoimmune diseases. The company's primary product candidate is Soquelitinib (CPI-818), an oral, small-molecule drug that selectively inhibits ITK (interleukin-2-inducible T cell kinase). The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).

Share on Social Networks: